1999. 3. - 2001. 2.; MS (Major in Signal Transduction), Department of Life Science, POSTECH, Pohang, Korea 2001. 3. - 2004. 8.; Ph. D. (Major in Signal Transduction), Department of Life Science, POSTECH, Pohang, Korea 2004. 9. - 2007. 6.; Post-doctoral Fellow  POSTECH Biotech Center,  POSTECH, Pohang, Korea. 2007. 7. - 2012. 2; Research Fellow in Dr. Bruce M. Spiegelman’s Lab. Division of Metabolism and Chronic Diseases, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.  2012. 2. - present; Assistant Professor UNIST, School of Nano-Bioscience and Chemical Engineering 

 Obesity is a major risk factor for metabolic disorders such as type 2 diabetes, dyslipidemia, cardiovascular disease and cancers. The number of patients with diabetes is rapidly increasing and is reaching the levels of infectious diseases. Our lab is interested in understanding the molecular pathways that link adipose tissue biology to this staggering array of pathologies such as diabetes and metabolic disorders. These studies can be the scientific basis for developing novel anti-diabetic agents.